News
March 29, 2023

More than 1,200 LOINC® registrants represent 78 countries for version 2.74 webinar

Biannual webinar assists interoperability experts

LOINC®, an international data standard maintained at Regenstrief Institute, hosted an educational release webinar for version 2.74. More than 1,200 participants signed up, representing 78 countries.

The hour and a half webinar served as an opportunity for the LOINC team to introduce and explain the new concepts from the 2.74 release update. Participants were presented with opportunities to learn more about each new concept and ask questions.

LOINC, short for Logical Observation Identifiers Names and Codes, is a global standard for health terminology. Created and maintained at Regenstrief, LOINC enables the identification, exchange and collection of data across health systems and is used around the world.

Of the 608 new concepts presented in the 2.74 update release in February, some were issued in coordination with the U.S. Food and Drug Administration, the U.S. Centers for Disease Control and Prevention and the Association of Public Health Laboratories.

Of the new concepts, 464 are focused on laboratory, 95 are focused on clinical and 49 are focused on surveys. LOINC version 2.74 prioritized concepts are centered around Lyme disease, the monkeypox virus, evaluation methods related to the SARS-Cov-2 virus and identifying bacteria, viruses and fungi in veterinary specimens.

LOINC’s long-term funding is supported by U.S. federal agencies and other organizations. LOINC is available free of charge. Regenstrief Institute releases updates to LOINC twice per year, in February and August.

The webinar will be available later online here: https://loinc.org/webinar/.

About LOINC®
LOINC was created in 1994 at Regenstrief Institute to facilitate interoperability in healthcare. There was a growing trend to send clinical data electronically between healthcare entities, a practice that has now become ubiquitous. Today, it contains almost 95,000 terms for everything from a serum alpha 1 antitrypsin level to a zygomatic arch X-ray report. For each concept, LOINC contains many other rich details, such as synonyms, units of measure, and carefully crafted descriptions.

About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

Related News

Kurt Kroenke, MD

The Impact of Patient Race, Patient Socioeconomic Status, and Cognitive Load of Physician Residents and Fellows on Chronic Pain Care Decisions

Published in the Journal of Pain. Here is a link to the article.  Regenstrief Institute authors:  Kurt Kroenke, PhD 

Shaun Grannis and Brian Dixon

Latest booster reduces adults’ risk of moderate or severe COVID by more than half

The most recent COVID-19 booster shot reduces adults’ risk of moderate or severe COVID by more than half, according

LOINC Version 2.77 - Now Available Worldwide

New LOINC® semiannual release highlights health equity projects with national and international partners

LOINC® from Regenstrief Institute’s semiannual content update highlights the comprehensive nature of its work with international partners, including supporting